← Back to all signals
RESEARCH PAPER ANALYSIS

Examining the Relationship Between Chronic Pain and Mortality in U.S. Adults.

AI interpretation is pending for this paper.

Open original publication →
PMID38942415
JournalThe journal of pain
Publication Date2024-06-26
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Chronic pain (CP) significantly impacts quality of life and increases noncommunicable disease risk, with recent U.S. data showing a 6.3% incidence rate, surpassing diabetes, depression, and hypertension. International studies suggest higher mortality in CP populations, yet prior U.S. data are inconclusive. To investigate CP's mortality risk, we analyzed National Health Interview Survey and National Death Index data. We hypothesized that individuals with CP and high-impact CP (HICP [≥1 activity limitation]) would exhibit higher mortality rates. National Health Interview Survey provided demographics, pain reporting, lifestyle, and psychosocial data matched with National Death Index mortality records. Chi-square analyses explored the relationships between CP/HICP and demographics, lifestyle factors, psychosocial variables, and mortality. Cox proportional hazards models assessed mortality risk between groups. The weighted sample was 245,899,776; 20% reported CP and 8% HICP, both groups exhibiting higher mortality rates than pain-free individuals (CP: 5.55%, HICP: 8.79%, total: 2.82%). Hazard ratios indicated nearly double the mortality risk for CP and 2.5 times higher risk for HICP compared to those without these conditions. Adjusting for lifestyle and psychosocial factors reduced mortality risk but remained elevated compared with non-CP individuals. Heart disease, malignant neoplasms, and chronic lower respiratory diseases accounted for a higher percentage of deaths in CP cases. CP individuals showed higher rates of smoking, alcohol consumption, obesity, inactivity, depression, anxiety, emotional problems, and sleep disturbances. CP and HICP significantly influence mortality outcomes, leading to excess deaths compared with pain-free individuals. Given the relationship between pain, lifestyle, psychosocial variables, and mortality, further investigations are needed into CP causation and prevention strategies. PERSPECTIVE: This article presents evidence regarding the relationship between CP, HICP, and mortality. Additional findings are discussed regarding the impact of demographics, lifestyle, and psychosocial variables on mortality in those with versus without CP and HICP. These findings are crucial for informing future research, prevention, and healthcare management strategies.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Potentially Clinically Beneficial Interactions Between Biologically-Based Complementary Medicines and Cancer Treatment: A Systematic Scoping Review. Integrative cancer therapies 87.24 2 RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status. Scientific reports 53.7 3 A de novo IKZF4 Variant Underlies Hypogammaglobulinemia and Increased Infection Susceptibility through Downregulating the NF-κB Pathway. Journal of clinical immunology 51.0 4 The impact of chemotherapy on frontal lobe executive functioning in adolescents and young adults diagnosed and treated for blood cancers: a systematic review. BMC cancer 77.14 5 Cutaneous angiomyolipoma presenting as a pilonidal cyst: a case report. Journal of medical case reports 45.5 6 Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study. Orphanet journal of rare diseases 65.0 7 A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance. Cellular oncology (Dordrecht, Netherlands) 57.2 8 Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. Cytotherapy 71.7 9 [Testicular leukemia and its treatment in prepubertal males: An update]. Zhonghua nan ke xue = National journal of andrology 68.84 10 Beyond Depression: Suicidality As the First Clue to a Silent Brain Tumor in the Elderly. Cureus 47.5 11 An Atypical Case of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis With Isolated Lower Airway Involvement in a Young Adult. Cureus 58.56 12 Indoor radon monitoring through citizen science in Catalan schools: environmental assessment and educational outcomes. Frontiers in public health 59.5 13 Diet meets biologics: accelerating remission in pediatric Crohn's disease - a real-world experience. Frontiers in gastroenterology (Lausanne, Switzerland) 69.76 14 Dyadic associations between perceived family resilience and fear of disease progression among reproductive-age patients with cervical cancer and their spouses: a cross-sectional study. Frontiers in oncology 64.0 15 Bone marrow CD14+CD206+ M2-like monocyte-macrophages as a potential complementary biomarker for bone marrow MRD in high-risk neuroblastoma. Frontiers in oncology 63.75 16 Comparative analysis of respiratory infection and clinical outcomes in Saudi hematology: malignant versus non-malignant cohorts. Frontiers in cellular and infection microbiology 57.2 17 Assessment of computational methods for fusion transcript detection in targeted RNA-seq samples. Frontiers in bioinformatics 56.0 18 The golden hour: the feasibility of a quality improvement project to decrease the time to antibiotic administration in children with cancer and febrile neutropenia in Jordan. Frontiers in pediatrics 67.9 19 Human models for human diseases: how pluripotent stem cell derived brain organoids can help us understand and treat diffuse hemispheric glioma. Frontiers in cell and developmental biology 50.0 20 Therapeutic enhancement and toxicity reduction of total glucosides of paeony combined with conventional therapy in juvenile idiopathic arthritis: a meta-analysis and network pharmacology. Frontiers in pediatrics 89.7 21 Single-stage combined cardiac and abdominal wall reconstruction in Pentalogy of Cantrell using a cemented sandwich mesh technique: a case report. Frontiers in pediatrics 51.0 22 Metabolic reprogramming in the immune microenvironment of Ewing sarcoma: from mechanisms to therapeutic strategies. Frontiers in immunology 75.5 23 Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease-Free Survival in Osteosarcoma Patients. Cancer medicine 68.62 24 Paediatric Bone Marrow Transplant Outcomes. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 60.7 25 The Hidden Burden: Addressing Disparities in Childhood Cancer Incidence Trends. Cancer reports (Hoboken, N.J.) 38.6 26 Geographic patterns of platform-reported pediatric major-disease cases and healthcare inequality in China: spatial associations and cross-regional healthcare seeking. International journal for equity in health 67.9 27 Carcinoembryonic antigen (CEA) is a useful screening biomarker for inherited glycosylphosphatidylinositol deficiencies. Molecular genetics and metabolism 58.35 28 Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan. Clinical case reports 56.3 29 Physiological Uterine Uptake of 18F-MFBG During Menstruation in a Pediatric Patient With Neuroblastoma. Clinical nuclear medicine 68.6 30 ATRT and ETMR: distinct tumors, shared clinical challenges-a comparative narrative review. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 72.1 31 A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging. The British journal of radiology 57.62 32 Response to comment on: "Immune checkpoint therapy in pediatric and adolescent lymphomas". Haematologica 52.36
PATIENT-FRIENDLY SUMMARY

Examining the Relationship Between Chronic Pain and Mortality in U.S. Adults.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic